Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$328.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,659 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER | 1,659 | — | — | +1.4% | Open the original filing on SEC.gov |
| May 19 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 12,000 | — | — | — | Open the original filing on SEC.gov |
| May 19 | TVTX | Travere Therapeutics, Inc. | AGRANT | 4,000 | — | — | +7.0% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 8,000 | $41.07 | $328.6K | -12.2% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 8,000 | $16.33 | $130.6K | +13.9% | Open the original filing on SEC.gov |